Could less radiation be enough for HPV throat cancer?
NCT ID NCT07497607
First seen Apr 03, 2026 · Last updated May 15, 2026 · Updated 9 times
Summary
This study is for people with HPV-positive throat cancer who are scheduled for standard chemoradiation. It tests whether giving a lower radiation dose (30 Gy) to the tumor and nearby lymph nodes can still control the cancer while reducing side effects. About 31 participants will be followed for 2 years to see how well the cancer is kept in check and to monitor quality of life and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Cincinnati Medical Center
Cincinnati, Ohio, 45219, United States
Contact
Conditions
Explore the condition pages connected to this study.